Jasmin D. Haslbauer

2.1k total citations · 1 hit paper
24 papers, 1.3k citations indexed

About

Jasmin D. Haslbauer is a scholar working on Infectious Diseases, Neurology and Oncology. According to data from OpenAlex, Jasmin D. Haslbauer has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Neurology and 7 papers in Oncology. Recurrent topics in Jasmin D. Haslbauer's work include COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Jasmin D. Haslbauer is often cited by papers focused on COVID-19 Clinical Research Studies (16 papers), Long-Term Effects of COVID-19 (9 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). Jasmin D. Haslbauer collaborates with scholars based in Switzerland, Austria and United States. Jasmin D. Haslbauer's co-authors include Alexandar Tzankov, Kirsten D. Mertz, Ronny Nienhold, Thomas Menter, Markus Tolnay, Niels Willi, Gieri Cathomas, Stefano Bassetti, Hans Pargger and Stephan Frank and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Jasmin D. Haslbauer

21 papers receiving 1.3k citations

Hit Papers

Postmortem examination of COVID‐19 patients reveals diffu... 2020 2026 2022 2024 2020 250 500 750

Peers

Jasmin D. Haslbauer
Jack L. Harbert United States
Edana Stroberg United States
Daniel Turek Switzerland
Subha Ghosh United States
Xiunan Li China
Nicole Yarid United States
Jack L. Harbert United States
Jasmin D. Haslbauer
Citations per year, relative to Jasmin D. Haslbauer Jasmin D. Haslbauer (= 1×) peers Jack L. Harbert

Countries citing papers authored by Jasmin D. Haslbauer

Since Specialization
Citations

This map shows the geographic impact of Jasmin D. Haslbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmin D. Haslbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmin D. Haslbauer more than expected).

Fields of papers citing papers by Jasmin D. Haslbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmin D. Haslbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmin D. Haslbauer. The network helps show where Jasmin D. Haslbauer may publish in the future.

Co-authorship network of co-authors of Jasmin D. Haslbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmin D. Haslbauer. A scholar is included among the top collaborators of Jasmin D. Haslbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmin D. Haslbauer. Jasmin D. Haslbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosch, Salome, Baptiste Hamelin, Jasmin D. Haslbauer, et al.. (2025). Human mastadenovirus pneumonia in two immunocompetent patients. Virology Journal. 22(1). 198–198.
2.
Vetter, Michael, et al.. (2024). Case report: 65-year-old man with metachronous left sided adrenal metastasis of hepatocellular carcinoma. International Journal of Surgery Case Reports. 119. 109683–109683.
3.
Haslbauer, Jasmin D., Vessela S. Ivanova, Thomas Menter, et al.. (2024). Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma. Infectious Agents and Cancer. 19(1). 33–33.
4.
Hamelin, Baptiste, Philippe Pérot, Jasmin D. Haslbauer, et al.. (2024). Circovirus Hepatitis in Immunocompromised Patient, Switzerland. Emerging infectious diseases. 30(10). 2140–2144. 5 indexed citations
5.
Berg, J., Jasmin D. Haslbauer, Anna K. Stalder, et al.. (2023). Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies. Research and Practice in Thrombosis and Haemostasis. 7(4). 100182–100182. 9 indexed citations
6.
Haslbauer, Jasmin D., Spasenija Savic Prince, Anna K. Stalder, et al.. (2023). Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series. Pathobiology. 91(2). 158–168. 4 indexed citations
7.
Nägele, Felix, Michael Graber, Jakob Hirsch, et al.. (2022). Correlation between structural heart disease and cardiac SARS-CoV-2 manifestations. SHILAP Revista de lepidopterología. 2(1). 142–142. 4 indexed citations
8.
Haslbauer, Jasmin D., Anna Luger, Florian Augustin, et al.. (2022). Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation. Pathobiology. 90(2). 138–146. 2 indexed citations
9.
Haslbauer, Jasmin D., Anna K. Stalder, Stefano Bassetti, et al.. (2021). Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19. Pathobiology. 89(3). 166–177. 4 indexed citations
10.
Zychowski, Diana, Pamela L. Lutsey, Jasmin D. Haslbauer, et al.. (2021). Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients. EClinicalMedicine. 41. 101139–101139. 21 indexed citations
11.
Krasniqi, Fatime, et al.. (2021). Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study. Case Reports in Oncology. 14(2). 706–715. 20 indexed citations
12.
Haslbauer, Jasmin D., Anna K. Stalder, Thomas Menter, et al.. (2021). Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19. Frontiers in Immunology. 12. 763098–763098. 11 indexed citations
13.
Haslbauer, Jasmin D., Matthias S. Matter, Anna K. Stalder, & Alexandar Tzankov. (2021). Reaktionsmuster der lokoregionären Lymphknoten im Abflussgebiet von COVID-19-Lungen. Der Pathologe. 42(2). 188–196. 4 indexed citations
14.
Haslbauer, Jasmin D., Matthias S. Matter, Anna K. Stalder, & Alexandar Tzankov. (2021). Histomorphological patterns of regional lymph nodes in COVID-19 lungs. Der Pathologe. 42(S1). 89–97. 20 indexed citations
15.
Juškevičius, Darius, et al.. (2021). Genomic Landscape of Hodgkin Lymphoma. Cancers. 13(4). 682–682. 14 indexed citations
16.
Menter, Thomas, Jasmin D. Haslbauer, Ronny Nienhold, et al.. (2020). Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 77(2). 198–209. 834 indexed citations breakdown →
17.
Henkel, Maurice, Thomas Weikert, Nathalie Schwab, et al.. (2020). Lethal COVID-19: Radiologic-Pathologic Correlation of the Lungs. Radiology Cardiothoracic Imaging. 2(6). e200406–e200406. 21 indexed citations
18.
Nienhold, Ronny, Yari Ciani, Viktor H. Koelzer, et al.. (2020). Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nature Communications. 11(1). 5086–5086. 171 indexed citations
19.
Haslbauer, Jasmin D., Valeria Perrina, Matthias S. Matter, et al.. (2020). Retrospective Post-mortem SARS-CoV-2 RT-PCR of Autopsies with COVID-19-Suggestive Pathology Supports the Absence of Lethal Community Spread in Basel, Switzerland, before February 2020. Pathobiology. 88(1). 95–105. 8 indexed citations
20.
Haslbauer, Jasmin D., Silvia Valbuena-López, Hui Zhou, et al.. (2018). CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping. International Journal of Cardiology. 275. 179–186. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026